Raina Setzer knows the work she does matters. That’s because she’s already seen it from the other side. Setzer, a radiochemical processing technician in Oak Ridge National Laboratory’s Isotope Processing and Manufacturing Division, joined the lab in June 2023.
In June, ORNL hit a milestone not seen in more than three decades: producing a production-quality amount of plutonium-238
Researchers at the Department of Energy’s Oak Ridge National Laboratory are supporting the grid by improving its smallest building blocks: power modules that act as digital switches.
Researchers at ORNL explored radium’s chemistry to advance cancer treatments using ionizing radiation.
Researchers at the Department of Energy’s Oak Ridge National Laboratory and their technologies have received seven 2022 R&D 100 Awards, plus special recognition for a battery-related green technology product.
More than 50 current employees and recent retirees from ORNL received Department of Energy Secretary’s Honor Awards from Secretary Jennifer Granholm in January as part of project teams spanning the national laboratory system. The annual awards recognized 21 teams and three individuals for service and contributions to DOE’s mission and to the benefit of the nation.
Of the $61 million recently announced by the U.S. Department of Energy for quantum information science studies, $17.5 million will fund research at DOE’s Oak Ridge National Laboratory. These projects will help build the foundation for the quantum internet, advance quantum entanglement capabilities — which involve sharing information through paired particles of light called photons — and develop next-generation quantum sensors.
As a medical isotope, thorium-228 has a lot of potential — and Oak Ridge National Laboratory produces a lot.
To minimize potential damage from underground oil and gas leaks, Oak Ridge National Laboratory is co-developing a quantum sensing system to detect pipeline leaks more quickly.
A rare isotope in high demand for treating cancer is now more available to pharmaceutical companies developing and testing new drugs.